“We have to make companies want to do this work”
Incentivising innovation in antibiotic research is now a must

The home stretch
Will short-term financial issues scupper efforts to make homecare a major pillar of UK healthcare?

Multiple sclerosis – the next generation

Are patients really getting what they need?

Just say no
The UK needs to re-energise its clinical trials industry, but sponsors need to know when to walk away from unreasonable costs

Clinical detail
PharmaTimes Magazine talks to this year’s International Clinical Researcher of the Year winners 

The R&D machine
Is it time for pharma to stop plugging away at research and switch to open innovation with universities?

Data wars
The bottom line is absolute transparency and no more dirty secrets in the NHS, 
says Phil Hammond